Investors with a short-term perspective can buy the stock of Sequent Scientific at current levels. The stock has been in a medium-term uptrend since taking support at ₹42 in early October 2018. Short-term trend is also up.
In early January, the stock decisively breached a key medium-term resistance level of ₹75 and continued to trend upwards. The stock trades well above its 50- and 200-day moving averages. On Monday, the stock advanced 4 per cent strengthening the bullish momentum with good volume.
There has been an increase in daily volume over the past two weeks. The daily as well as the weekly relative strength indices are hovering in the bullish zone backing the uptrend. Moreover, the daily and weekly price rate of change indicators features in the positive terrain implying buying interest.
The short-term outlook is bullish for the stock. It can extend the current uptrend and reach the price targets of ₹90.5 and ₹92 in the ensuing trading sessions. Traders can buy the stock with a stop-loss at ₹84.5.
(Note: The recommendations are based on technical analysis. There is a risk of loss in trading.)
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.